Jonathan D Root has an estimated net worth of $1.17 Billion. This is based on reported shares across multiple companies, which include Mellanox Technologies, Ltd., Inspire Medical Systems, Inc., Intersect ENT, Inc., AtriCure, Inc., BOX INC, MAXLINEAR INC, Altus Pharmaceuticals Inc., LEADIS TECHNOLOGY INC, INTERMOLECULAR INC, OCCAM NETWORKS INC/DE, @ROAD, INC, CURON MEDICAL INC, CASTLIGHT HEALTH, INC., IMPERVA INC, Guidewire Software, Inc., Inari Medical, Inc., Edgewise Therapeutics, Inc., Silverback Therapeutics, Inc., eFFECTOR Therapeutics, Inc., OncoMed Pharmaceuticals Inc, Omada Health, Inc., and CARLSMED, INC..
2007 was Jonathan D Root's most active year for acquiring shares with 26 total transactions. Jonathan D Root's most active month to acquire stocks was the month of October. 2012 was Jonathan D Root's most active year for disposing of shares, totalling 48 transactions. Jonathan D Root's most active month to dispose stocks was the month of October. 2003 saw Jonathan D Root paying a total of $10,909,100.00 for 1,090,910 shares, this is the most they've acquired in one year. In 2012 Jonathan D Root cashed out on 21,906,458 shares for a total of $98,431,979.17, their largest year based on trade value.